| Carter L Murphy, OD | |
|
5251 John Tyler Hwy Ste 7, Williamsburg, VA 23185-8808 | |
| (757) 229-8660 | |
| (757) 258-8845 |
| Full Name | Carter L Murphy |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 5251 John Tyler Hwy Ste 7, Williamsburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538236880 | NPI | - | NPPES |
| 9203257 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0601000591 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carter L Murphy, OD 5251 John Tyler Hwy Ste 7, Williamsburg, VA 23185-8808 Ph: (757) 229-8660 | Carter L Murphy, OD 5251 John Tyler Hwy Ste 7, Williamsburg, VA 23185-8808 Ph: (757) 229-8660 |
News Archive
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, today announced that its wholly-owned subsidiary, 22nd Century Limited, LLC, enrolled the first patients in its Phase II-B clinical trial for X-22, a prescription smoking cessation aid in development.
Cepheid today reported revenues for the second quarter of 2012 of $81.0 million, representing growth of 21% from $67.0 million for the second quarter of 2011.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has been selected as the Bioscience Company of the Year by the University of Colorado with its 7th Annual Technology Transfer Awards in recognition of its leadership position in developing a pipeline of novel protein therapeutics that modulate the complement system to treat a wide range of inflammatory diseases.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Clinically, kidney fibrosis can be used to assess stage, progression, and prognosis for both kidney transplants and kidney disease. There is debate as to whether kidney fibrosis is a maladaptive, injury-triggered process that inherently progresses to kidney failure or an adaptive wound-healing process that stabilizes the injury site.
› Verified 5 days ago
Eye 2 Eye Vision Center Pc Optometrist Medicare: Medicare Enrolled Practice Location: 1147 Professional Dr Ste A, Williamsburg, VA 23185 Phone: 757-259-2300 Fax: 757-259-2302 | |
Eyewear Plus Optometric Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 Tewning Rd, Williamsburg, VA 23188 Phone: 757-229-1131 | |
Hampton Roads Eye Associates-williamsburg Optometrist Medicare: Medicare Enrolled Practice Location: 120 Kings Way, Suite 1300, Williamsburg, VA 23185 Phone: 757-345-1001 Fax: 757-345-3102 | |
Mrs. Laureen Goddard Waldron, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4630 Monticello Ave, Williamsburg, VA 23188 Phone: 757-253-7901 Fax: 757-253-7928 | |
Eye Center Of Virginia Optometrist Medicare: Medicare Enrolled Practice Location: 101 Tewning Rd, Williamsburg, VA 23188 Phone: 757-229-1131 Fax: 757-229-1586 | |
Waldron Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 4630 Monticello Ave, Williamsburg, VA 23188 Phone: 757-253-7901 Fax: 757-253-7928 | |
Williamsburg Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 101 Bulifants Blvd Ste A, Williamsburg, VA 23188 Phone: 757-564-1907 Fax: 757-564-1913 |